CA48226-2 - 0x0000000000006734
Males & Females of Non-Childbearing Potential
Jewel
* El estipendio puede pagar hasta el monto reflejado.
Start Date:
July 23, 2025 - 5:30am
End Date:
September 9, 2025 - 11:30am
Study Details
Study Number: CA48226
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $11,500.00
Study Criteria
Age: 19 - 55
BMI: 18.5 - 29.9
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed to treat atrial fibrillation.
Route of Administration: Oral
Blood Draws: 50
Study Schedule
Schedule Type: Long Term
Study Length: 19 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 7/15/2025 |
| Wednesday | 7/16/2025 |
| Thursday | 7/17/2025 |
| Friday | 7/18/2025 |
| Monday | 7/21/2025 |
| Tuesday | 7/22/2025 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 7/15/2025 |
| Wednesday | 7/16/2025 |
| Thursday | 7/17/2025 |
| Friday | 7/18/2025 |
| Monday | 7/21/2025 |
| Tuesday | 7/22/2025 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 7/23/2025 5:30:00 AM | 8/11/2025 9:00:00 AM | 1 | Lincoln | |
| Phone participant | Tuesday | 9/9/2025 11:30:00 AM | 3 | Lincoln |
